Long survival in a patient with brain metastases from breast cancer

Clinical Medicine: Oncology

Volumn 2, Issue , 2008, Pages 103-108

  Sanna, Giuseppina ^a   Petralia, G ^a   Cossu Rocca, M ^a   Marenghi, C ^a   Nole F ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Advanced breast cancer; Brain metastases; Treatment

Indexed keywords

EID: 84911903393     PISSN: None     EISSN: 11779314     Source Type: Journal    
DOI: 10.4137/cmo.s317     Document Type: Article

References (22)

1. Crivellari, D., Pagani, O., Veronesi, A. et al. 2001. International Breast Cancer Study Group. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer. Ann. Oncol., 12:353-6.
2. DiStefano, A., Yong Yap, Y., Hortobagy, G.N. et al. 1979. The natural history of breast cancer patients with brain metastases. Cancer, 44:1913-8.
3. Zimm, S., Wampler, G.L., Stablein, D. et al. 1981. Intracerebral metastases in solid tumour patients: natural history and results of treatment. Cancer, 48:384-94.
4. Goyal, S., Prasad, D., Harrell, F. Jr., et al. 2005, Aug. Gamma knife surgery for the treatment of intracranial metastases from breast cancer. J. Neurosurg., 103(2):218-23.
5. Akyurek, S., Chang, E.L., Mahajan, A. et al. 2007, Jun. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am. J. Clin. Oncol., 30(3):310-4.
6. Sanna, G., Franceschelli, L., Rotmensz, N. et al. 2007, Jul-Aug. Brain metastases in patients with advanced breast cancer (ABC). Anticancer Res., 27(4C):2865-9.
7. Corej, J., Langer, Minesh, P. Metha, 2005. September 1. Current management of brain metastases, with a focus on systemic options. Journal of Clinical Oncology, 23(25):6207-19.
8. Sawaya, R., Bindal, R., Lang, F. et al. 2001. Metastatic Tumours. brain tumours: An Encyclopedic Approach. edited by Kaye AH, Laws ER., Jr., New York. Churchill Livingstone, pp. 999-1026.
9. Weil, R.J., Palmieri, D.C., Bronder, J.L. et al. 2005. October. Breast Cancer Metastasis to Central Nervous System, Review. American Journal of Pathology, 167(4):913-20.
10. Altaha, R et., Cromwell, E., Hobbs Gerry. et al. 2005, Feb 1. Increased risk of brain Metastases in Patients with HER-2/neu-positive Breast Carcinoma. Cancer, 103(3):442-3.
11. Miller, K.D., Weathers, L., Haney, G. et al. 2003, Jul. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann. Oncol., 14(7):1072-7.
12. Clayton, A., Danson, S., Jolly, S., Ryder, W. et al. 2004. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br. J. Cancer, 91:639-43.
13. Kirsch, D.G., Carlos, J., Ledezma, Christina, S. et al. 2005, Mar. Survival after brain metastases from breast Cancer in the Trastuzumab Era, 2005. J. Clin. Oncol., 23(9):2114-6.
14. Lai, R., Dang, C.T., Malkin, M.G. et al. 2004, August 15. The risk of Central Nervous System Metastases after Trastuzumab Therapy in Patients with Breast Cancer. Cancer, 101(4):810-6.
15. Viani, G.A., Castilho, M.S., Salvajoli, J.V. et al. 2007, Mar. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems. BMC Cancer, 26;7:53.
16. Muacevic, A., Kreth, F.W., Tonn, J.C. et al. 2004, Apr. Stereotactic radiosurgery for multiple brain metastases from breast carcinoma. Cancer, 100(8):1705-11.
17. Gaspar, L., Scott, C., Rotman, M. et al. 1997, Mar. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys., 37(4):745-51.
18. Gaspar, L.E., Scott, C., Murray, K. et al. 2000, Jul 1. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int. J. Radiat. Oncol. Biol. Phys., 47(4):1001-6.
19. Lorenzoni, J., Devriendt, D., Massager, N. et al. 2004, Sep 1. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int. J. Radiat. Oncol. Biol. Phys., 60(1):218-24.
20. Grossi, P.M., Ochiai, H., Archer, G.E. et al. 2003. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin. Cancer Res., 9:5514-20.
21. Moy, B. and Goss, P.E. 2006, Nov-Dec. Lapatinib: current status and future directions in breast cancer. Oncologist, 11(10):1047-57.
22. Lin, N.U., Carey, L.A., Liu, M.C. et al. 2006. Phase II trial of lapatinib for brain metastases in patients with HER2 breast cancer. J. Clin. Oncol., 24(suppl 18):3S.